Substituted dispensing and generic prescription under adverse impact.

The false bio-equivalency test recently detected by the KFDA seems to give a serious adverse impact to the pharmacist group's plans for the substituted dispensing and the prescriptions in generic drug names.

The pharmacist group strongly urged the KFDA to uncover the suspicion over the manipulated bio-equivalency tests by thoroughly inspecting the subjected institutes, considering the fact ...